Abstract
(Molecular Therapy: Oncolytics 18, 579–586; September 2020) In the originally published version of this article, Figure 1D had “MCF7 / mammary ASC” image inadvertently included from “MCF7 / SAT ASC” group. In the corrected Figure 1, MCF7 data are replaced from an independent experiment, which showed the same results as originally published. Figure 1E is correspondingly updated with new MCF7 graph bars based on new Figure 1D. The authors regret this error.[Formula
| Original language | English (US) |
|---|---|
| Pages (from-to) | 305-306 |
| Number of pages | 2 |
| Journal | Molecular Therapy Oncolytics |
| Volume | 25 |
| DOIs |
|
| State | Published - Jun 16 2022 |
ASJC Scopus subject areas
- Molecular Medicine
- Oncology
- Cancer Research
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis (Molecular Therapy - Oncolytics (2020) 18 (579–586), (S2372770520301297), (10.1016/j.omto.2020.08.012))'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS